PBA
EYPT icon

Paradigm Biocapital Advisors’s EyePoint Inc EYPT Stock Holding History

Paradigm Biocapital Advisors’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3M Sell
2,890,397
-252,040
-8% -$3.37M 0.77% 21
2026
Q1 		$40.5M Sell
3,142,437
-549,038
-15% -$8.21M 0.83% 25
2025
Q4 		$67.4M Buy
3,691,475
+1,686,110
+84% +$23.9M 1.72% 16
2025
Q3 		$28.6M Buy
+2,005,365
New +$23.1M 0.81% 27

Other funds holding EYPT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paradigm Biocapital Advisors's EYPT Position: Q2 2026 in Review

Paradigm Biocapital Advisors reduced its EyePoint Inc (EYPT) stake by 8% in Q2 2026, selling an estimated $3.37M and leaving 2,890,397 shares worth $41.3M. The position accounts for 0.77% of the portfolio, ranked #21.

Paradigm Biocapital Advisors first reported a position in EYPT in Q3 2025 and has held it in 4 quarters since. The position peaked at $67.4M in Q4 2025. 189 funds tracked by Wall St. Rank hold EYPT as of Q2 2026.

  • Paradigm Biocapital Advisors held 2,890,397 shares of EyePoint Inc worth $41.3M as of Q2 2026.
  • Paradigm Biocapital Advisors sold 252,040 EyePoint Inc shares in Q2 2026, an estimated $3.37M.
  • EyePoint Inc made up 0.77% of Paradigm Biocapital Advisors's portfolio in Q2 2026, its #21 holding.
  • Paradigm Biocapital Advisors first reported a position in EyePoint Inc in Q3 2025 and has held it in 4 quarters since.
  • Paradigm Biocapital Advisors's EyePoint Inc position peaked at $67.4M in Q4 2025.
  • 189 funds tracked by Wall St. Rank held EyePoint Inc as of Q2 2026.

Based on Paradigm Biocapital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.